Skip to content

Insider · CIK 0001824720

Rashmi Kumar

director

Files at MYGN (MYRIAD GENETICS INC). First filing Jun 9, 2026, latest Jun 9, 2026.

In brief

Rashmi Kumar files SEC Form 4 as director at MYGN (MYRIAD GENETICS INC). Since Jun 9, 2026, Rashmi Kumar has reported 0 open-market buys worth $0 and 1 open-market sell worth $67k, the latest filed on Jun 9, 2026.

A track record needs three past buys with six months of prices behind them; Rashmi Kumar has 0, so none is measured yet.

The newest scored trade: sold $67k of MYGN on Jun 8, 2026, filed Jun 9, 2026, scored 3 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 1 sell worth $67k.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $67k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

MYGN: MYRIAD GENETICS INC

MYGNOct 12, 2026 · close 4.20

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
3Weak
MYGNsell10b5-1
MYRIAD GENETICS INC
$67k
15,000 shares
-8%+24% from low-46% from high

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Jun 8, 2026 MYGN
MYRIAD GENETICS INC
15,000
0.02% of outstanding
$69kJun 8, 2026none

Transactions

Every row this insider has filed, 3 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 8, 2026MYGN
MYRIAD GENETICS INC
SOpen-market sale
Common Stock10b5-1
-15,000$4.46$67k171,889Jun 9, 2026
Jun 4, 2026MYGN
MYRIAD GENETICS INC
AGrant or award
Common Stock
+59,701$0.00$0186,889Jun 5, 2026
Jun 5, 2025MYGN
MYRIAD GENETICS INC
AGrant or award
Common Stock
+49,796$0.00$0127,188Jun 6, 2025

Questions about Rashmi Kumar

Answered from the filings on this page, as of the latest one.

Is Rashmi Kumar buying or selling?

In the last 12 months Rashmi Kumar reported 0 open-market buys worth $0 and 1 open-market sell worth $67k on SEC Form 4; the latest was sold $67k of MYGN on Jun 8, 2026. Grants, option exercises and tax withholding are not counted.

How did Rashmi Kumar's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Rashmi Kumar has 0.

Where does Rashmi Kumar file Form 4?

Rashmi Kumar has filed Form 4 at MYGN (MYRIAD GENETICS INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Rashmi Kumar: insider trades and track record | InsiderTell